Neil E. Stahl - 11 Dec 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research and Development
Signature
/s/**Neil Stahl
Issuer symbol
REGN
Transactions as of
11 Dec 2021
Net transactions value
-$500,248
Form type
4
Filing time
14 Dec 2021, 15:08:00 UTC
Previous filing
10 Dec 2021
Next filing
08 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Tax liability $500,248 -753 -1.4% $664.34 53,130 11 Dec 2021 Direct
holding REGN Common Stock 5,792 11 Dec 2021 By 401(k) Plan
holding REGN Common Stock 4,605 11 Dec 2021 by Spouse as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.